driven Cre-transgenic mouse and a mouse homozygous for a floxed Epas1 allele (Epas1 fl/fl ) or a double heterozygote for a floxed Epas1 allele and a universal null Epas1 allele (Epas1 fl/-), respectively. Each of the three mouse lines has been extensively characterized and used in previous studies 5 .
At Fig. 1a ). In addition, accumulation of HIF-2α protein was severely decreased in embryonic day 15.5 (E15.5) Prx1-Cre; Epas1 fl/-hindlimb paws when compared to controls ( Supplementary  Fig. 1b) ; the very modest residual signal observed in mutant specimens was probably the result of background staining. Whole-mount alizarin red S and alcian blue staining of mutant skeletons at birth revealed no pattern defect and no difference in length of the long bones when compared to control specimens (Fig. 1a) . BrdU analysis performed at E15.5 did not show any change of chondrocyte proliferation rate in growth plates lacking HIF-2α ( Supplementary Fig. 1c) ; moreover, we did not observe any difference in TUNEL staining in mutants versus controls (data not shown).
We then pursued a systematic analysis of tibias and paws at various stages of fetal and postnatal development by routine histology and in situ hybridization. E13.5 mutant paws were histologically indistinguishable from controls; in particular, the appearance of Col10a1 mRNAexpressing cells was not delayed by loss of HIF-2α (Fig. 1b and data not shown). These findings indicate that HIF-2α is dispensable for mesenchymal condensations, for differentiation of mesenchymal cells into chondrocytes and for Col10a1 mRNA expression, at least at early stages of cartilage formation. Of note, during endochondral bone development, accumulation of detectable levels of Col10a1 mRNA consistently preceded the appearance of hypertrophic chondrocytes (Fig. 1b) .
At E15.5, mutant tibia length was comparable to control ( Fig. 1c and data not shown), as was extension of the domain of expression of Col2a1 mRNA in the growth plate, whereas the extension of the domain of expression of Col10a1 mRNA and, in particular, of the subdomain expressing osteopontin (Spp1), Mmp13 and Vegfa mRNAs, was shorter in mutants, although the difference was statistically significant only for the subdomain (Fig. 1c and data not shown) . Osteopontin, MMP13 and VEGF are produced by late hypertrophic cells; that is, by those chondrocytes whose appearance immediately precedes blood vessel invasion and replacement of cartilage by bone. All in all, our findings thus indicate that, whereas appearance of Col10a1 mRNA-expressing cells is not affected by loss of HIF-2α, as shown by analysis of E13.5 hindlimb paw, differentiation of hypertrophic, Col10a1 mRNA-producing cells into late hypertrophic cells expressing Col10a1, Spp1, Mmp13 and Vegfa mRNAs is modestly, though significantly, impaired by lack of this transcription factor.
Consistent with these data, E17.5 mutant tibias were slightly shorter than controls; moreover, the distance between the two Col10a1 mRNA domains and, thus, the extension of the bone marrow cavity, were modestly decreased (Fig. 1d) , features that were all probably consequences of the delayed appearance of late hypertrophic chondrocytes and, therefore, of the delayed replacement of cartilage by bone. Of note, however, none of these differences reached statistical significance, which highlights the overall extremely modest nature of the phenotype in the mutants. Indeed, postnatally, mutants and controls were virtually indistinguishable, as shown by whole-mount alizarin red S and alcian blue staining, routine histology and in situ hybridization (Fig. 1a, Supplementary  Fig. 1d and data not shown) .
In summary, differently from what we might have predicted on the basis of the findings in Epas1 +/− mice reported by Saito et al. 3 , homozygous loss of HIF-2α in limb bud mesenchyme achieved by conditional knockout causes only a modest delay of endochondral bone development. More important, differently from what Saito et al. 3 suggests, this delay is not due to impairment of Col10A1 accumulation, as Col10A1 expression is very robust and occurs in a timely manner in growth plates lacking HIF-2α, but rather is secondary to a very modest impairment of differentiation of hypertrophic cells into late hypertrophic chondrocytes. Last, the delay of endochondral bone development in mutants is transient and no longer detectable in postnatal life.
In conclusion, the role of HIF-2α in growth plate development and, particularly, in expression of Col10a1 mRNA, is not as crucial as it is in articular surface homeostasis. Identification of the molecular and cellular mechanisms responsible for this difference requires further studies.
